Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Formic Acid | HCID 284 | — |
| Edukt | Toluene | HCID 1140 | — |
| Edukt | Trityl candesartan cilexetil | HCID 11029254 | — |
| Lösungsmittel | Methanol | HCID 887 | — |
| Produkt | Candesartan Cilexetil | HCID 2540 | — |
Reaktionsschritte
Typically, the deprotection step comprises heating to reflux trityl candesartan cilexetil in methanol. Optionally, the deprotection solvent mixture further comprises an organic solvent, such as toluene, and/or an acid, such as formic acid. The cilexetil trityl candesartan is heated to reflux until a clear solution is obtained. Typically, the reaction temperature is from about 30° C. to about 90° C., preferably from about 50° C. to about 90° C., and the heating takes place for about 5 to about 19 hours, preferably for about 8 to about 12 hours. Thereafter, the solvents are removed by evaporation to obtain crude deprotected candesartan cilexetil. The solvents may be removed at a temperature of about 30° C. to about 70° C., preferably at a temperature of about 50° C., and at a reduce pressure of about 30 mbar.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US07098342B2 |
|---|
| Quelldatensatz | uspto-grants-2006_08 |
|---|
| ORD ID | ord-9ddc7e8714f848aa8be681a6021447c6 |
|---|
| Quellennotiz | uspto-grants-2006_08 |
|---|